tanshinone has been researched along with ex 527 in 1 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (ex 527) | Trials (ex 527) | Recent Studies (post-2010) (ex 527) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 225 | 2 | 209 |
| Protein | Taxonomy | tanshinone (IC50) | ex 527 (IC50) |
|---|---|---|---|
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 2.725 | |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 0.3666 | |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Homo sapiens (human) | 6.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dai, Y; Fu, L; Lv, Y; Qi, B; Qian, Y; Quan, M | 1 |
1 other study(ies) available for tanshinone and ex 527
| Article | Year |
|---|---|
Tanshinone IIA protects against lipopolysaccharide-induced lung injury through targeting Sirt1.
Topics: Abietanes; Acute Lung Injury; Animals; Carbazoles; Cytokines; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Shock, Septic; Signal Transduction; Sirtuin 1; Transcription Factor RelA | 2019 |